The United States authorized Moderna as the 2nd COVID-19 vaccine for emergency use. With death tolls climbing to 2,500 per day, the United States now has two vaccines approved. The first approval was for the COVID-19 vaccine by Pfizer and BioNTech which was already being given to frontliners in the US.
The two-dose Moderna vaccine is also based on mRNA or messenger ribonucleic acid technology which was studied to be 95% more effective than placebo.
Moderna proposed to ship 20 million vaccines in December and 80 million more for the first quarter of 2021 and 100 million by the second quarter.